CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation

被引:57
作者
Abou-Rjaily, GA
Lee, SJ
May, D
Al-Share, QY
DeAngelis, AM
Ruch, RJ
Neumaier, M
Kalthoff, H
Lin, SH
Najjar, SM
机构
[1] Med Coll Ohio, Dept Pharmacol & Therapeut, Toledo, OH 43614 USA
[2] Ivonex GmbH, Kiel, Germany
[3] Med Coll Ohio, Dept Pathol, Toledo, OH 43614 USA
[4] Univ Clin Mannheim, Inst Clin Chem, Mannheim, Germany
[5] Univ Hosp Schleswig Holstein, Clin Gen & Thorac Surg, Kiel, Germany
[6] Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA
关键词
D O I
10.1172/JCI200421786
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Phosphorylation of the cell adhesion protein CEACAM1 increases insulin sensitivity and decreases insulin-dependent mitogenesis in vivo. Here we show that CEACAM1 is a substrate of the EGFR and that upon being phosphorylated, CEACAM1 reduces EGFR-mediated growth of transfected Cos-7 and MCF-7 cells in response to EGF. Using transgenic mice overexpressing a phosphorylation-defective CEACAM1 mutant in liver (L-SACC1), we show that the effect of CEACAM1 on EGF-dependent cell proliferation is mediated by its ability to bind to and sequester Shc, thus uncoupling EGFR signaling from the ras/MAPK pathway. In L-SACCI mice, we also show that impaired CEACAM1 phosphorylation leads to ligand-independent increase of EGFR-mediated cell proliferation. This appears to be secondary to visceral obesity and the metabolic syndrome, with increased levels of output of free fatty acids and heparin-binding EGF-fike growth factor from the adipose tissue of the mice. Thus, L-SACC1 mice provide a model for the mechanistic link between increased cell proliferation in states of impaired metabolism and visceral obesity.
引用
收藏
页码:944 / 952
页数:9
相关论文
共 59 条
[1]  
Accili Domenico, 2001, Current Molecular Medicine (Hilversum), V1, P9, DOI 10.2174/1566524013364040
[2]  
Baldeweg SE, 2000, EUR J CLIN INVEST, V30, P45
[3]  
BALDWIN S, 1986, Nutrition and Cancer, V8, P273
[4]   Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[5]   SIGNAL-TRANSDUCTION VIA THE MAP KINASES - PROCEED AT YOUR OWN RSK [J].
BLENIS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5889-5892
[6]  
BRUMMER J, 1995, ONCOGENE, V11, P1649
[7]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[8]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[9]   Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera [J].
Carter, RE ;
Sorkin, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35000-35007
[10]   Insulin stimulates pp120 endocytosis in cells co-expressing insulin receptors [J].
Choice, CV ;
Howard, MJ ;
Poy, MN ;
Hankin, MH ;
Najjar, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22194-22200